Canada to allow import of J&J vaccine doses made at Emergent facility

(Reuters) – The Canadian health regulator said on Wednesday it would allow Johnson & Johnson to import its COVID-19 vaccine made at contract manufacturer Emergent BioSolutions Inc’s plant in Baltimore, Maryland.

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)